Followers | 9844 |
Posts | 260028 |
Boards Moderated | 4 |
Alias Born | 12/27/2006 |
Tuesday, December 03, 2019 4:53:57 PM
Link to Video - click here to watch the technical chart video
Recent AMRX News
- Amneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administration • Business Wire • 09/05/2024 08:05:00 PM
- Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials • Business Wire • 08/20/2024 03:26:00 PM
- Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials • Business Wire • 08/20/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/14/2024 07:12:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/14/2024 03:04:22 PM
- UBS Beats Earnings Forecasts, Intel Divests Arm Holdings, Flutter Surges 9% in Premarket Trading, and More • IH Market News • 08/14/2024 09:56:35 AM
- Amneal Reports Second Quarter 2024 Financial Results • Business Wire • 08/09/2024 10:05:00 AM
- Amneal Receives U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease to Be Launched as CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules • Business Wire • 08/07/2024 08:45:00 PM
- Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags • Business Wire • 07/29/2024 08:05:00 PM
- Amneal to Report Second Quarter 2024 Results on August 9, 2024 • Business Wire • 07/11/2024 08:05:00 PM
- Amneal Launches FOCINVEZ™, the First Ready-to-Use Version of Fosaprepitant • Business Wire • 07/09/2024 08:05:00 PM
- Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab) • Business Wire • 07/01/2024 12:00:00 PM
- Amneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar • Business Wire • 07/01/2024 12:00:00 PM
- Amneal Releases 2023 Environmental, Social and Governance Report • Business Wire • 06/28/2024 12:00:00 PM
- Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies • Business Wire • 06/05/2024 12:00:00 PM
- Amneal to Participate at Upcoming Investor Conference • Business Wire • 05/22/2024 08:05:00 PM
- Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California • Business Wire • 05/22/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/16/2024 07:13:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:45:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:45:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:43:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:42:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:18:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2024 09:35:55 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM